Piramal Pharma has reported a remarkable increase in its consolidated net profit for the second quarter ending September 2024, posting over a four-fold jump to Rs 23 crore. This is a significant rise compared to the Rs 5 crore net profit the company achieved during the same period last fiscal year.

The Mumbai-based pharmaceutical firm also reported an increase in its revenue from operations, which grew to Rs 2,242 crore during the July-September quarter. This marks a solid improvement from the Rs 1,911 crore revenue reported in the corresponding period of the previous year, as per the company's official statement.